PTEN and myotubularin phosphoinositide phosphatases: Bringing bioinformatics to the lab bench

Current Opinion in Cell Biology

Volumn 13, Issue 2, 2001, Pages 172-181

  Wishart, Matthew J ^a   Taylor, Gregory S ^a   Slama, James T ^b   Dixon, Jack E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MYOTUBULARIN; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ENZYME ANALYSIS; ENZYME ISOLATION; INFORMATION SCIENCE; LABORATORY AUTOMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0035313805     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00195-2     Document Type: Review

References (72)

1. Signalling through phosphoinositide 3-kinases: The lipids take centre stage
2. Pathways for phosphoinositide synthesis
3. Phosphoinositides in membrane traffic
4. Phosphoinositide signaling and the regulation of membrane trafficking in yeast
5. Protein tyrosine phosphatases: Mechanisms of catalysis and regulation
6. PTEN, a putative tyrosine phosphatase gene mutated in human brain breast, and prostate cancer
7. Identification of a candidate tumor suppressor gene MMAC1 at chromosome 10q23.3 that is mutated in multiple advanced cancers
8. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
9. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway
10. PTEN: A tumour suppressor that functions as a phospholipid phosphatase
11. P-TEN the tumor suppressor from human chromosome 10q23 is a dual-specificity phosphatase
12. The tumor suppressor PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
13. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephorylates the lipid second messenger, phosphatidylinositol 3-phosphate
14. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway
15. Characterization of a myotubularin dual specificity phosphatase gene family from yeast to human
16. The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling
17. The multiple roles of PTEN in tumor suppression
18. AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation
19. Forkhead transcription factors: New insights into protein kinase B (c-akt) signaling
20. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB
21. Protein kinases: Six degrees of separation?
22. Serine/threonine protein kinases and apoptosis
23. Intracellular signalling: PDK1-a kinase at the hub of things
24. The PI3K-PDK1 connection: More than just a road to PKB
25. Cellular signaling: Pivoting around PDK-1
26. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
27. Impaired Fas response and autoimmunity in Pten +/- mice
28. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene
29. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN
30. The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway
31. PTEN affects cell size, cell proliferation and apoptosis in during Drosophila eye development
32. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway
33. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways
34. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways
35. The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila
36. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes
37. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-trisphosphate and Akt/protein kinase B pathway
38. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
39. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death
40. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
41. Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor
42. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
43. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: Evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1
44. Increased Akt activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression
45. Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association
46. 2+-binding domain
47. The tumor suppressor activity of PTEN is regulated by its carboxyl-terminal region
48. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene
49. Phosphorylation of PTEN tail regulates protein stability and function
50. The tumor suppressor is phosphorylated by the protein kinase CK2 at its C-terminus: Implications for PTEN stability to proteosome-mediated degradation
51. Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding
52. Evidence for regulation of PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2
53. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase
54. A testis-specific gene, TPTE, encodes a putative transmembrane tyrosine phosphatase and maps to the pericentromeric region of human chromosomes 21 and 13, and to chromosomes 15, 22, and Y
55. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine family conserved in yeast
56. MTM1 mutations in X-linked myotubular myopathy
57. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2
58. Association of SET domain and myotubularin-related proteins modulates growth control
59. Sac phosphatase domain proteins
60. A sensitive assay for phosphoinositide phosphatases
61. SAC-1 domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases
62. SAC1 encodes a regulated lipid phosphoinositide phosphatase, defects in which can be suppressed by the homologous Inp52p and Inp53p phosphatases
63. Functional characterization of a mammalian Sac1 and mutants exhibiting substrate specific defects in phosphoinositide phosphatase activity
64. FYVE fingers bind PtdIns(3)P
65. A functional PtdIns(3)P-binding motif
66. Phosphatidylinositol 3-phosphate signaling mediated by specific binding to RING FYVE domains
67. FYVE-DSP1, a dual-specificity protein phosphatase containing an FYVE domain
68. A single mutation converts a novel phosphotyrosine binding domain into a dual-specificity phosphatase
69. Gathering STYX: Phosphatase-like form predicts functions for unique protein-interaction domains
70. GRAM, a novel domain in glucosyltransferases, myotubularins, and other putative membrane-associated proteins
71. SMART: A web-based tool for the study of genetically mobile domains
72. Forkhead transcription factors a critical effectors of cell death and cell cycle arrest downstream of PTEN